{"id":67964,"date":"2026-10-23T14:44:46","date_gmt":"2026-10-23T09:14:46","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=67964"},"modified":"2026-10-23T15:08:54","modified_gmt":"2026-10-23T09:38:54","slug":"new-series-of-interactive-cardiology-mcqs-10","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/","title":{"rendered":"New Series of Interactive Cardiology MCQs 10"},"content":{"rendered":"\n<!-- \n  INSTRUCTIONS FOR WORDPRESS:\n  1. Add a new \"Custom HTML\" block in your WordPress editor.\n  2. Copy everything from line 1 to the end of this file.\n  3. Paste it into the Custom HTML block.\n  4. Preview or Publish the post to see the interactive MCQs in action.\n-->\n\n<script src=\"https:\/\/cdn.tailwindcss.com\"><\/script>\n<script>\n  tailwind.config = {\n    corePlugins: {\n      preflight: false, \/\/ Ensures maximum compatibility with WordPress themes\n    }\n  }\n<\/script>\n\n<div class=\"cardio-quiz-wrapper font-sans bg-slate-950 text-slate-200 p-4 md:p-8 rounded-3xl max-w-4xl mx-auto shadow-2xl relative overflow-hidden my-8 border border-cyan-900\/50\" style=\"box-sizing: border-box; font-family: 'Inter', system-ui, sans-serif;\">\n  \n  <!-- Ambient Dark Medical Theme Glows -->\n  <div class=\"absolute top-0 left-0 w-full h-full pointer-events-none opacity-20 bg-[radial-gradient(ellipse_at_top,_var(--tw-gradient-stops))] from-cyan-600 via-slate-900 to-slate-950\"><\/div>\n  \n  <!-- Header Banner -->\n  <div class=\"relative text-center pb-6 border-b border-cyan-900\/50 mb-8\">\n    <div class=\"inline-block bg-gradient-to-r from-cyan-600 to-teal-600 text-white font-black text-xs md:text-sm px-4 py-1.5 rounded-full uppercase tracking-widest shadow-lg shadow-cyan-900\/50 mb-4\">\n      Advanced Clinical Series\n    <\/div>\n    <h1 class=\"text-3xl md:text-5xl font-extrabold tracking-tight text-transparent bg-clip-text bg-gradient-to-r from-cyan-400 to-teal-300 m-0 drop-shadow-md\">\n      Cardiology MCQs: Part 10\n    <\/h1>\n    <p class=\"text-sm md:text-base text-slate-400 mt-3 max-w-2xl mx-auto font-medium\">\n      Master-level assessment spanning complex hemodynamics, electrophysiology, structural interventions, and landmark clinical trials.\n    <\/p>\n  <\/div>\n\n  <!-- Sticky Live Scoreboard -->\n  <div class=\"sticky top-4 z-40 bg-slate-900\/85 backdrop-blur-xl border border-cyan-800\/60 rounded-2xl p-4 md:p-5 mb-8 shadow-xl shadow-cyan-900\/20 flex flex-wrap items-center justify-between gap-4 transition-all\">\n    <div class=\"flex items-center gap-4\">\n      <div class=\"w-12 h-12 rounded-full bg-cyan-950 flex items-center justify-center border border-cyan-700 shadow-inner text-cyan-400\">\n        <svg class=\"w-6 h-6\" fill=\"none\" stroke=\"currentColor\" viewBox=\"0 0 24 24\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path stroke-linecap=\"round\" stroke-linejoin=\"round\" stroke-width=\"2\" d=\"M9 12l2 2 4-4M7.835 4.697a3.42 3.42 0 001.946-.806 3.42 3.42 0 014.438 0 3.42 3.42 0 001.946.806 3.42 3.42 0 013.138 3.138 3.42 3.42 0 00.806 1.946 3.42 3.42 0 010 4.438 3.42 3.42 0 00-.806 1.946 3.42 3.42 0 01-3.138 3.138 3.42 3.42 0 00-1.946.806 3.42 3.42 0 01-4.438 0 3.42 3.42 0 00-1.946-.806 3.42 3.42 0 01-3.138-3.138 3.42 3.42 0 00-.806-1.946 3.42 3.42 0 010-4.438 3.42 3.42 0 00.806-1.946 3.42 3.42 0 013.138-3.138z\"><\/path><\/svg>\n      <\/div>\n      <div>\n        <div class=\"text-[10px] md:text-xs uppercase font-extrabold tracking-widest text-teal-500\">Live Score<\/div>\n        <div class=\"text-xl md:text-3xl font-black text-slate-100 flex items-baseline gap-1\">\n          <span id=\"score-correct\">0<\/span>\n          <span class=\"text-slate-500 text-sm md:text-lg font-bold\">\/ 25<\/span>\n        <\/div>\n      <\/div>\n    <\/div>\n    <div class=\"flex items-center gap-3 bg-slate-950\/80 px-4 py-2 rounded-xl border border-slate-800\">\n      <span class=\"text-xs font-bold text-slate-400 uppercase tracking-widest hidden sm:inline\">Progress<\/span>\n      <div class=\"w-24 md:w-32 bg-slate-800 h-2.5 rounded-full overflow-hidden\">\n        <div id=\"progress-bar\" class=\"bg-gradient-to-r from-cyan-500 to-teal-500 h-full w-0 transition-all duration-500 rounded-full\"><\/div>\n      <\/div>\n      <span class=\"text-xs font-bold text-cyan-400\"><span id=\"score-answered\">0<\/span>\/25<\/span>\n    <\/div>\n  <\/div>\n\n  <!-- Quiz Questions Container -->\n  <div class=\"space-y-6 relative\" id=\"mcq-container\">\n    \n    <!-- Q1 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">1.<\/span> \n        Which of the following represents the classic electrocardiographic hallmark of Brugada Syndrome Type 1?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"true\" data-explanation=\"Type 1 Brugada is definitively characterized by a prominent coved ST-segment elevation &gt; 2 mm in at least one right precordial lead (V1-V3), followed by a negative symmetric T wave.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Coved ST segment elevation &gt; 2mm in V1-V3 followed by a negative T wave<\/button><button data-correct=\"false\" data-explanation=\"Saddle-back ST elevation describes Type 2 or Type 3 Brugada patterns, which are suggestive but not definitively diagnostic without conversion to Type 1.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Saddle-back ST elevation &gt; 1mm in V1-V3 followed by a negative T wave<\/button><button data-correct=\"false\" data-explanation=\"Epsilon waves in the right precordial leads are characteristic of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), not Brugada.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Epsilon waves immediately following the QRS complex in V1-V3<\/button><button data-correct=\"false\" data-explanation=\"Prolonged QTc with T wave alternans is characteristic of Long QT Syndrome.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Prolonged QTc interval exceeding 500 ms with macroscopic T wave alternans<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q2 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">2.<\/span> \n        During simultaneous right and left heart catheterization, which of the following hemodynamic profiles strongly favors Constrictive Pericarditis over Restrictive Cardiomyopathy?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Concordant changes (pressures moving in the same direction) suggest restrictive cardiomyopathy.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Concordant changes in LV and RV systolic pressures during respiration<\/button><button data-correct=\"true\" data-explanation=\"Discordant changes in ventricular systolic pressures during respiration (e.g., LV pressure falls while RV pressure rises during inspiration) indicate enhanced ventricular interdependence, the hemodynamic hallmark of Constrictive Pericarditis.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Discordant LV and RV systolic pressure changes during respiration<\/button><button data-correct=\"false\" data-explanation=\"A difference &gt; 5 mmHg between LVEDP and RVEDP favors restrictive cardiomyopathy. Constriction usually shows equalization.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) LVEDP exceeding RVEDP by more than 10 mmHg<\/button><button data-correct=\"false\" data-explanation=\"Severe pulmonary hypertension (PA systolic &gt; 50-60 mmHg) is common in restriction but rare in constriction.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Pulmonary artery systolic pressure greater than 60 mmHg<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q3 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">3.<\/span> \n        Among patients undergoing Transcatheter Aortic Valve Replacement (TAVR), which valve design historically carries the highest risk of causing conduction blocks requiring a permanent pacemaker?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Balloon-expandable valves (like the Edwards SAPIEN) have a lower rate of permanent pacemaker implantation compared to self-expanding valves.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Balloon-expandable valves (e.g., Sapien 3)<\/button><button data-correct=\"true\" data-explanation=\"Self-expanding valves (like CoreValve\/Evolut) exert continuous, ongoing outward radial force on the LVOT and AV node after deployment, leading to historically higher rates of new Left Bundle Branch Block and the need for permanent pacing.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Self-expanding valves (e.g., CoreValve\/Evolut)<\/button><button data-correct=\"false\" data-explanation=\"Surgical bioprostheses have a much lower rate of conduction disturbances than TAVR valves overall.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Surgical stented porcine bioprostheses<\/button><button data-correct=\"false\" data-explanation=\"Sutureless surgical valves (like Perceval) have pacemaker risks, but self-expanding TAVR valves are the classic high-risk culprit in interventional boards.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Sutureless surgical aortic valves<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q4 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">4.<\/span> \n        Which of the following genes represents the most common genetic mutation responsible for Hypertrophic Cardiomyopathy (HCM)?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"MYH7 (beta-myosin heavy chain) is the second most common cause, accounting for roughly 25-30% of genotyped cases.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) MYH7 (Beta-myosin heavy chain)<\/button><button data-correct=\"true\" data-explanation=\"Mutations in MYBPC3 (Myosin-binding protein C) are the most frequent genetic cause of Hypertrophic Cardiomyopathy, accounting for a large plurality of positive genotypes.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) MYBPC3 (Myosin-binding protein C)<\/button><button data-correct=\"false\" data-explanation=\"TNNT2 (Cardiac troponin T) mutations cause HCM, often with mild hypertrophy but a disproportionately high risk of sudden death, but they are less common than MYBPC3.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) TNNT2 (Cardiac troponin T)<\/button><button data-correct=\"false\" data-explanation=\"SCN5A mutations cause Brugada syndrome, Long QT type 3, and certain dilated cardiomyopathies, not typical HCM.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) SCN5A (Voltage-gated sodium channel)<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q5 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">5.<\/span> \n        Sacubitril, a key component of foundational heart failure therapy, exerts its clinical benefit via which specific mechanism of action?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Direct inhibition of the renin enzyme is achieved by Aliskiren, not Sacubitril.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Direct renin inhibition<\/button><button data-correct=\"true\" data-explanation=\"Sacubitril is a prodrug that inhibits neprilysin, a neutral endopeptidase. This inhibition prevents the breakdown of beneficial natriuretic peptides (like BNP) and bradykinin, leading to vasodilation, natriuresis, and reduced fibrosis.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Neprilysin inhibition, preventing breakdown of natriuretic peptides<\/button><button data-correct=\"false\" data-explanation=\"Blockade of the angiotensin II type 1 receptor is accomplished by Valsartan, the other half of the ARNI combination drug.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Blockade of the angiotensin II type 1 receptor<\/button><button data-correct=\"false\" data-explanation=\"Aldosterone antagonism is the mechanism of Spironolactone and Eplerenone.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Mineralocorticoid receptor antagonism<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q6 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">6.<\/span> \n        Which of the following organisms belongs to the fastidious HACEK group, a known cause of culture-negative infective endocarditis?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Coxiella burnetii causes Q fever and is a major cause of culture-negative endocarditis, but it is not part of the HACEK group.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Coxiella burnetii<\/button><button data-correct=\"false\" data-explanation=\"Bartonella species cause culture-negative endocarditis (often in the homeless or those with cat exposure) but are not HACEK organisms.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Bartonella henselae<\/button><button data-correct=\"true\" data-explanation=\"The HACEK group comprises Haemophilus species, Aggregatibacter, Cardiobacterium hominis, Eikenella corrodens, and Kingella species. These are slow-growing Gram-negative bacilli.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Cardiobacterium hominis<\/button><button data-correct=\"false\" data-explanation=\"Staphylococcus lugdunensis is an aggressive coagulase-negative staph, but it grows readily in standard cultures and is not a HACEK organism.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Staphylococcus lugdunensis<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q7 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">7.<\/span> \n        According to ACC\/AHA guidelines, which of the following patient profiles represents a Class I indication for Cardiac Resynchronization Therapy (CRT)?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"CRT is less effective in RBBB; guidelines give it a Class IIa or IIb indication depending on QRS width, but not Class I.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) LVEF &lt;= 35%, sinus rhythm, RBBB with QRS &gt;= 150ms<\/button><button data-correct=\"true\" data-explanation=\"A guideline-directed Class I indication for CRT requires symptomatic HFrEF (EF &lt;= 35%), normal sinus rhythm, Left Bundle Branch Block (LBBB) morphology, and a wide QRS duration (&gt;= 150 ms).\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) LVEF &lt;= 35%, sinus rhythm, LBBB with QRS &gt;= 150ms<\/button><button data-correct=\"false\" data-explanation=\"An EF of 40% (mildly reduced) without an indication for right ventricular pacing is not an indication for CRT.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) LVEF &lt;= 40%, sinus rhythm, LBBB with QRS &lt; 130ms<\/button><button data-correct=\"false\" data-explanation=\"While LBBB with QRS 130-149 ms is an indication, it is typically a Class IIa recommendation. A QRS &gt;= 150 ms is required for a definitive Class I recommendation.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) LVEF &lt;= 35%, sinus rhythm, LBBB with QRS 120-149ms<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q8 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">8.<\/span> \n        Maternal use of which medication during the first trimester of pregnancy is classically associated with an increased risk of Ebstein anomaly in the fetus?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Valproic acid is primarily associated with neural tube defects (like spina bifida).\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Valproic acid<\/button><button data-correct=\"false\" data-explanation=\"Warfarin is associated with fetal warfarin syndrome (nasal hypoplasia, chondrodysplasia punctata), not Ebstein anomaly.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Warfarin<\/button><button data-correct=\"true\" data-explanation=\"Lithium, used for bipolar disorder, is the classic pharmacological teratogen associated with the apical displacement of the tricuspid valve leaflets known as Ebstein anomaly.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Lithium<\/button><button data-correct=\"false\" data-explanation=\"Phenytoin causes fetal hydantoin syndrome (cleft lip\/palate, microcephaly, hypoplastic nails).\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Phenytoin<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q9 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">9.<\/span> \n        Which of the following is a hallmark physical examination finding indicative of cardiac tamponade?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Kussmaul sign (rise in JVP with inspiration) is classic for constrictive pericarditis or restrictive CM, but is typically ABSENT in cardiac tamponade.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Kussmaul sign<\/button><button data-correct=\"false\" data-explanation=\"Pulsus alternans (alternating strong and weak pulses) is a sign of severe left ventricular failure.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Pulsus alternans<\/button><button data-correct=\"true\" data-explanation=\"Pulsus paradoxus is defined as an abnormally large drop in systolic blood pressure (&gt; 10 mmHg) during inspiration. It is a critical, classic sign of cardiac tamponade driven by enhanced ventricular interdependence.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Pulsus paradoxus<\/button><button data-correct=\"false\" data-explanation=\"Water-hammer (Corrigan's) pulse is a bounding, rapidly collapsing pulse seen in severe aortic regurgitation.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Water-hammer pulse<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q10 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">10.<\/span> \n        Wellens Syndrome warns of a critical, impending occlusion of the proximal Left Anterior Descending (LAD) artery. What is its characteristic ECG pattern observed during a pain-free interval?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"This represents an acute anteroseptal STEMI, whereas Wellens represents a pre-infarction, reperfused, or critically narrowed state seen during a pain-free window.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Massive ST segment elevation in V1-V3 with Q waves<\/button><button data-correct=\"true\" data-explanation=\"Wellens syndrome (Type A and B) is characterized by deeply inverted or biphasic T waves in the anterior precordial leads (usually V2-V3) during a pain-free state, with preserved R waves and no significant ST elevation.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Deeply inverted or biphasic T waves in leads V2-V3<\/button><button data-correct=\"false\" data-explanation=\"Diffuse ST depression with aVR elevation is characteristic of Left Main coronary artery occlusion or severe triple-vessel disease.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Diffuse ST depression across multiple leads with ST elevation in aVR<\/button><button data-correct=\"false\" data-explanation=\"Hyperacute, tall, peaked symmetric T waves in anterior leads indicate the very earliest stages of an active occlusion (or De Winter pattern if preceded by ST depression), not Wellens.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Hyperacute, tall peaked T waves in V2-V6<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q11 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">11.<\/span> \n        Which class of antihypertensive medications is strictly contraindicated in patients with Heart Failure with Reduced Ejection Fraction (HFrEF)?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Beta-blockers (specifically carvedilol, metoprolol succinate, and bisoprolol) are a cornerstone of HFrEF guideline-directed medical therapy.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Beta-blockers<\/button><button data-correct=\"true\" data-explanation=\"Non-dihydropyridine CCBs (like Verapamil and Diltiazem) have powerful negative inotropic effects. They can severely depress cardiac contractility, exacerbating heart failure, and are strictly contraindicated in HFrEF.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Non-dihydropyridine calcium channel blockers<\/button><button data-correct=\"false\" data-explanation=\"ACE inhibitors reduce afterload and mortality in HFrEF and are a foundational therapy.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) ACE inhibitors<\/button><button data-correct=\"false\" data-explanation=\"Thiazides and loop diuretics are safely used for fluid management and symptom control in HFrEF.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Thiazide diuretics<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q12 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">12.<\/span> \n        In echocardiography, which empirical formula is utilized to estimate the Mitral Valve Area (MVA) based on the diastolic Pressure Half-Time (PHT)?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"true\" data-explanation=\"The widely accepted empirical formula used in echocardiography to estimate the Mitral Valve Area in mitral stenosis is MVA = 220 \/ PHT.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) MVA = 220 \/ PHT<\/button><button data-correct=\"false\" data-explanation=\"This is a distractor. The numerator is a constant (220), not the denominator.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) MVA = PHT \/ 220<\/button><button data-correct=\"false\" data-explanation=\"MVA is inversely proportional to PHT (a longer time means a smaller hole), so multiplying them is incorrect.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) MVA = 220 x PHT<\/button><button data-correct=\"false\" data-explanation=\"This uses the constant for calculating Pulmonary Valve or Tricuspid Valve area (though rarely used), not the Mitral Valve constant of 220.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) MVA = 759 \/ PHT<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q13 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">13.<\/span> \n        What was the primary conclusion of the landmark ISCHEMIA trial regarding the management of patients with stable, moderate-to-severe coronary artery disease?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"The invasive strategy failed to show a statistically significant reduction in major cardiovascular events or mortality.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) A routine invasive strategy significantly reduced all-cause mortality<\/button><button data-correct=\"true\" data-explanation=\"The ISCHEMIA trial demonstrated that in stable patients, an initial routine invasive strategy (angiography and PCI\/CABG) did not reduce the risk of major ischemic cardiovascular events or death compared to optimal medical therapy alone.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) A routine invasive strategy did not reduce major ischemic events compared to optimal medical therapy alone<\/button><button data-correct=\"false\" data-explanation=\"The trial actually showed that the invasive strategy (revascularization) was SUPERIOR to medical therapy for relieving angina symptoms and improving quality of life, even though it didn't reduce mortality.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Medical therapy was superior to PCI for immediate angina relief<\/button><button data-correct=\"false\" data-explanation=\"The trial compared an invasive strategy against a conservative strategy; it was not designed to establish the superiority of CABG over PCI.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) CABG was superior to PCI for long-term all-cause mortality<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q14 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">14.<\/span> \n        During echocardiographic evaluation of a large pericardial effusion, which of the following findings is the MOST specific indicator of hemodynamic cardiac tamponade?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"RA collapse (specifically late diastolic\/early systolic) is an early and sensitive sign of tamponade, but it is not as highly specific as RV diastolic collapse.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Right atrial systolic collapse<\/button><button data-correct=\"true\" data-explanation=\"Right ventricular free wall inversion (collapse) during early diastole is highly specific for cardiac tamponade. It proves that intrapericardial pressure has exceeded the normal right ventricular filling pressures.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Right ventricular diastolic collapse<\/button><button data-correct=\"false\" data-explanation=\"A plethoric IVC with &lt; 50% collapse suggests elevated right heart pressures (sensitive for tamponade, right heart failure, or pulmonary hypertension) but is not specific to tamponade.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Dilated IVC with less than 50% inspiratory collapse<\/button><button data-correct=\"false\" data-explanation=\"Because the LV is a high-pressure, thick-walled chamber, LV diastolic collapse is an extremely late, pre-mortem sign, and is rarely seen compared to RV collapse.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Left ventricular diastolic collapse<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q15 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">15.<\/span> \n        In a patient presenting with rapid Atrial Fibrillation with pre-excitation (Wolff-Parkinson-White syndrome), which drug class is absolutely contraindicated for rate control?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Procainamide (a Class IA antiarrhythmic) slows conduction down the accessory pathway and is the drug of choice for hemodynamically stable AF with WPW.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Procainamide<\/button><button data-correct=\"true\" data-explanation=\"AV nodal blocking agents (Adenosine, Verapamil, Beta-blockers, Digoxin) are strictly contraindicated. Blocking the AV node removes its braking effect, allowing 100% of the rapid atrial impulses to surge down the accessory pathway, causing Ventricular Fibrillation.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) AV nodal blockers (e.g., Adenosine or Verapamil)<\/button><button data-correct=\"false\" data-explanation=\"Ibutilide is a Class III antiarrhythmic that acts on the accessory pathway and can be used cautiously to chemically cardiovert these patients.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Ibutilide<\/button><button data-correct=\"false\" data-explanation=\"Amiodarone is generally avoided due to some AV nodal properties, but it is not as universally catastrophic and strictly contraindicated as pure AV nodal blockers like Adenosine\/Verapamil.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Amiodarone<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q16 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">16.<\/span> \n        Which specific type of Atrial Septal Defect (ASD) is fundamentally an endocardial cushion defect and is highly associated with Down syndrome (Trisomy 21)?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Ostium secundum is the most common ASD overall in the general population, but it is not an endocardial cushion defect and is not the hallmark defect of Down syndrome.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Ostium secundum<\/button><button data-correct=\"true\" data-explanation=\"Ostium primum ASDs are located at the lower portion of the atrial septum and are part of the atrioventricular septal defect (AVSD) spectrum, which is classically associated with Down syndrome.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Ostium primum<\/button><button data-correct=\"false\" data-explanation=\"Sinus venosus ASDs are located high in the septum near the SVC and are classically associated with Partial Anomalous Pulmonary Venous Return (PAPVR), not Down syndrome.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Sinus venosus<\/button><button data-correct=\"false\" data-explanation=\"Coronary sinus ASDs are rare defects where the wall between the coronary sinus and left atrium is unroofed.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Coronary sinus<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q17 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">17.<\/span> \n        PCSK9 inhibitors (such as Evolocumab and Alirocumab) radically lower LDL cholesterol through which molecular mechanism?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Inhibition of cholesterol absorption at the brush border of the small intestine is the mechanism of Ezetimibe.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Inhibiting intestinal cholesterol absorption<\/button><button data-correct=\"true\" data-explanation=\"PCSK9 normally binds to hepatic LDL receptors, targeting them for lysosomal destruction. PCSK9 inhibitors block this binding, preventing degradation and leaving a massive surplus of LDL receptors on the hepatocyte surface to clear LDL from the blood.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Preventing the degradation of hepatic LDL receptors<\/button><button data-correct=\"false\" data-explanation=\"Direct inhibition of HMG-CoA reductase is the fundamental mechanism of statins.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Inhibiting HMG-CoA reductase<\/button><button data-correct=\"false\" data-explanation=\"Activating the PPAR-alpha receptor is the mechanism of action for Fibrates, which primarily lower triglycerides.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Activating the PPAR-alpha receptor<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q18 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">18.<\/span> \n        In patients with Congenital Long QT Syndrome Type 1 (LQT1), fatal arrhythmias (Torsades de Pointes) are most classically triggered by:\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Sudden auditory stimuli (like alarm clocks or ringing phones) are the classic trigger for Long QT Type 2 (LQT2).\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Sudden loud auditory stimuli (e.g., alarm clocks)<\/button><button data-correct=\"false\" data-explanation=\"Fatal events occurring during sleep or quiet rest are characteristic of Long QT Type 3 (LQT3), an SCN5A sodium channel mutation.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Sleep or periods of bradycardia at rest<\/button><button data-correct=\"true\" data-explanation=\"LQT1 (a KCNQ1 potassium channel mutation) fails to adequately shorten the QT interval during sympathetic surges. Thus, arrhythmias are classically triggered by intense adrenergic tone, most famously during swimming or strenuous physical exertion.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Swimming or strenuous physical exercise<\/button><button data-correct=\"false\" data-explanation=\"Eating or swallowing is a trigger for vagally mediated Brugada syndrome or neurally mediated syncope, but not classically LQT1.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Eating or swallowing cold liquids<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q19 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">19.<\/span> \n        For a patient with ischemic cardiomyopathy (at least 40 days post-MI and &gt; 90 days post-revascularization), which of the following establishes a Class I indication for a Primary Prevention Implantable Cardioverter-Defibrillator (ICD)?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"A patient with an LVEF &lt;= 40% requires an additional risk stratifier (like non-sustained VT and positive EP study) to warrant a primary prevention ICD. It is not an automatic indication.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) LVEF &lt;= 40% and NYHA Class I<\/button><button data-correct=\"false\" data-explanation=\"ICDs are generally not implanted for primary prevention within 40 days of an acute MI (DINAMIT and IRIS trials showed no mortality benefit due to competing risks of non-arrhythmic death).\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) LVEF &lt;= 35% evaluated 10 days post-acute myocardial infarction<\/button><button data-correct=\"true\" data-explanation=\"Based on landmark trials (SCD-HeFT), a primary prevention ICD is a Class I indication for patients with ischemic cardiomyopathy, an LVEF &lt;= 35%, and NYHA Class II or III symptoms on guideline-directed medical therapy.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) LVEF &lt;= 35% and NYHA Class II-III<\/button><button data-correct=\"false\" data-explanation=\"Patients with end-stage NYHA Class IV failure who are not candidates for CRT, transplant, or LVAD are generally not indicated for ICDs due to poor overall survival.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) LVEF &lt;= 35% and refractory NYHA Class IV heart failure<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q20 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">20.<\/span> \n        When prescribing dual antiplatelet therapy after a PCI, which patient history finding is an ABSOLUTE contraindication to the use of Prasugrel?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"true\" data-explanation=\"Prasugrel is absolutely contraindicated in patients with a history of a prior Transient Ischemic Attack (TIA) or ischemic stroke because it significantly increases the risk of fatal intracranial hemorrhage.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) History of prior TIA or ischemic stroke<\/button><button data-correct=\"false\" data-explanation=\"Age &gt;= 75 is a precaution for Prasugrel. It generally requires a dose reduction (from 10mg to 5mg) but is not an absolute contraindication.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Age greater than 75 years<\/button><button data-correct=\"false\" data-explanation=\"Low body weight (&lt; 60 kg) is a precaution requiring dose reduction (5mg daily), but not an absolute contraindication.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Body weight less than 60 kg<\/button><button data-correct=\"false\" data-explanation=\"Active pathological bleeding is a contraindication, but a distant history of GI bleeding is not an absolute contraindication, though caution is advised.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) History of remote gastrointestinal bleeding<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q21 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">21.<\/span> \n        In a patient suffering from third-degree (complete) AV block, which classic clinical sign may be observed in the jugular venous pulse (JVP)?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Giant, regular 'v waves' in the JVP denote severe tricuspid regurgitation.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Giant, regular V waves<\/button><button data-correct=\"false\" data-explanation=\"A prominent, rapid 'x descent' is classic for cardiac tamponade.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) A prominent, steep X descent<\/button><button data-correct=\"true\" data-explanation=\"In complete AV block, the atria and ventricles beat independently (AV dissociation). Whenever the right atrium happens to contract against a closed tricuspid valve (during RV systole), a massive regurgitant pressure wave is sent into the jugular vein, producing intermittent 'cannon A waves'.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Intermittent Cannon A waves<\/button><button data-correct=\"false\" data-explanation=\"Kussmaul sign (lack of inspiratory JVP collapse) is indicative of constrictive pericarditis or right heart failure, not AV block.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Kussmaul sign<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q22 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">22.<\/span> \n        Which of the following medications is a dual Endothelin Receptor Antagonist (ERA) used in the treatment of Group 1 Pulmonary Arterial Hypertension (PAH)?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Sildenafil is a Phosphodiesterase-5 (PDE-5) inhibitor.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Sildenafil<\/button><button data-correct=\"true\" data-explanation=\"Bosentan (along with Ambrisentan and Macitentan) is an Endothelin Receptor Antagonist that blocks the potent vasoconstrictive and proliferative effects of endothelin-1 on the pulmonary vasculature.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Bosentan<\/button><button data-correct=\"false\" data-explanation=\"Epoprostenol is a synthetic prostacyclin analog given as a continuous IV infusion for severe PAH.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Epoprostenol<\/button><button data-correct=\"false\" data-explanation=\"Riociguat is a soluble guanylate cyclase stimulator, notably used in CTEPH (Group 4) as well as PAH.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Riociguat<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q23 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">23.<\/span> \n        Which finding on Cardiac Magnetic Resonance (CMR) imaging is considered highly classic for Cardiac Amyloidosis?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Mid-wall septal striae are characteristic of non-ischemic dilated cardiomyopathy.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Linear mid-wall septal enhancement<\/button><button data-correct=\"true\" data-explanation=\"Massive extracellular deposition of amyloid fibrils classically produces a diffuse, global subendocardial (or transmural) late gadolinium enhancement (LGE) pattern, often accompanied by abnormal myocardial nulling.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Diffuse, global subendocardial late gadolinium enhancement<\/button><button data-correct=\"false\" data-explanation=\"Epicardial enhancement, often in the inferolateral wall, is characteristic of acute myocarditis.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Epicardial enhancement in the lateral wall<\/button><button data-correct=\"false\" data-explanation=\"Focal transmural enhancement conforming to a specific vascular territory indicates a completed myocardial infarction (scar).\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Focal transmural enhancement in a coronary territory<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q24 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">24.<\/span> \n        In approximately 10% of the population with a &quot;left-dominant&quot; coronary circulation, the Posterior Descending Artery (PDA) arises from which vessel?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"The LAD supplies the anterior septum and anterior wall, but does not wrap around to form the PDA.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Left Anterior Descending Artery (LAD)<\/button><button data-correct=\"true\" data-explanation=\"Coronary dominance is determined by the vessel that supplies the PDA and posterolateral branches. In a left-dominant system, the PDA arises from the terminal portion of the Left Circumflex Artery (LCx).\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Left Circumflex Artery (LCx)<\/button><button data-correct=\"false\" data-explanation=\"If the PDA arises from the RCA, the patient has a right-dominant circulation (which is the case for roughly 85% of people).\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Right Coronary Artery (RCA)<\/button><button data-correct=\"false\" data-explanation=\"The Ramus Intermedius is a trifurcation branch of the Left Main supplying the lateral wall, it does not course to the posterior interventricular groove.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Ramus Intermedius<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n    <!-- Q25 -->\n    <div class=\"mcq-card bg-slate-900 border border-slate-800 rounded-2xl p-5 md:p-6 shadow-md transition-all duration-300 hover:border-cyan-800\/50\" data-answered=\"false\">\n      <h3 class=\"text-lg md:text-xl font-bold text-slate-100 mb-5 leading-snug flex gap-3\">\n        <span class=\"text-cyan-500 font-black\">25.<\/span> \n        Which highly characteristic electrocardiographic finding in leads V1-V3 suggests the diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)?\n      <\/h3>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-2\"><button data-correct=\"false\" data-explanation=\"Delta waves signify pre-excitation down an accessory pathway, characteristic of Wolff-Parkinson-White syndrome.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">A) Delta wave<\/button><button data-correct=\"false\" data-explanation=\"Osborn (J) waves are prominent positive deflections at the J-point seen in severe hypothermia.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">B) Osborn wave<\/button><button data-correct=\"true\" data-explanation=\"An epsilon wave is a small, distinct positive notch or 'wobble' located at the very end of the QRS complex (or early ST segment) in the right precordial leads (V1-V3). It represents delayed right ventricular activation and is a major diagnostic criterion for ARVC.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">C) Epsilon wave<\/button><button data-correct=\"false\" data-explanation=\"Prominent U waves are the hallmark of severe hypokalemia, not ARVC.\" class=\"opt-btn w-full text-left p-4 rounded-xl border border-slate-700 bg-slate-950 hover:bg-slate-800 transition-all text-sm md:text-base font-semibold text-slate-300\">D) Prominent U wave<\/button><\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm leading-relaxed mt-4\"><\/div>\n    <\/div>\n\n  <\/div>\n<\/div>\n\n<script>\n  document.addEventListener('DOMContentLoaded', () => {\n    const cards = document.querySelectorAll('.mcq-card');\n    const scoreCorrectEl = document.getElementById('score-correct');\n    const scoreAnsweredEl = document.getElementById('score-answered');\n    const progressBar = document.getElementById('progress-bar');\n    \n    let correctCount = 0;\n    let answeredCount = 0;\n    const totalQuestions = cards.length;\n\n    cards.forEach(card => {\n      const buttons = card.querySelectorAll('.opt-btn');\n      const feedbackBox = card.querySelector('.feedback-box');\n\n      buttons.forEach(btn => {\n        btn.addEventListener('click', function() {\n          \n          \/\/ 1. Prevent answering more than once per card\n          if (card.getAttribute('data-answered') === 'true') return;\n          card.setAttribute('data-answered', 'true');\n          \n          answeredCount++;\n          \n          \/\/ 2. Safely extract attributes logic\n          const isCorrect = this.getAttribute('data-correct') === 'true';\n          const explanationText = this.getAttribute('data-explanation');\n\n          \/\/ 3. Update global UI Scoreboard\n          scoreAnsweredEl.innerText = answeredCount;\n          progressBar.style.width = `${(answeredCount \/ totalQuestions) * 100}%`;\n\n          if (isCorrect) {\n            correctCount++;\n            scoreCorrectEl.innerText = correctCount;\n          }\n\n          \/\/ 4. Style all buttons in the card\n          buttons.forEach(b => {\n            b.disabled = true;\n            b.classList.remove('hover:bg-slate-800', 'cursor-pointer');\n            b.classList.add('opacity-50', 'cursor-not-allowed');\n            \n            \/\/ Emphasize the correct answer\n            if (b.getAttribute('data-correct') === 'true') {\n              b.classList.remove('opacity-50', 'bg-slate-950', 'border-slate-700');\n              b.classList.add('opacity-100', 'bg-emerald-950', 'border-emerald-500', 'text-emerald-300');\n              b.innerHTML += ' <span class=\"float-right text-emerald-400 font-bold tracking-wider\">\u2713<\/span>';\n            }\n          });\n\n          \/\/ 5. Highlight the clicked wrong answer (if missed)\n          if (!isCorrect) {\n            this.classList.remove('opacity-50', 'bg-slate-950', 'border-slate-700');\n            this.classList.add('opacity-100', 'bg-rose-950', 'border-rose-500', 'text-rose-300');\n            this.innerHTML += ' <span class=\"float-right text-rose-400 font-bold tracking-wider\">\u2717<\/span>';\n          }\n\n          \/\/ 6. Show the explanation safely using Text Nodes\/Templates\n          feedbackBox.innerHTML = `\n            <div class=\"font-extrabold uppercase tracking-widest text-xs mb-1.5 ${isCorrect ? 'text-emerald-400' : 'text-rose-400'}\">\n              ${isCorrect ? 'Correct!' : 'Incorrect'}\n            <\/div>\n            <p class=\"m-0 text-slate-300\">${explanationText}<\/p>\n          `;\n          \n          feedbackBox.classList.remove('hidden');\n          feedbackBox.classList.add(\n            'block', \n            isCorrect ? 'bg-emerald-950\/30' : 'bg-rose-950\/30', \n            'border', \n            isCorrect ? 'border-emerald-900\/50' : 'border-rose-900\/50'\n          );\n        });\n      });\n    });\n  });\n<\/script>\n","protected":false},"excerpt":{"rendered":"<p>Advanced Clinical Series Cardiology MCQs: Part 10 Master-level assessment spanning complex hemodynamics, electrophysiology, structural interventions, and landmark clinical trials. Live Score 0 \/ 25 Progress 0\/25 1. Which of the following represents the classic electrocardiographic hallmark of Brugada Syndrome Type 1? A) Coved ST segment elevation &gt; 2mm in V1-V3 followed by a negative T [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":67965,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-67964","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cardiology-mcq"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New Series of Interactive Cardiology MCQs 10 - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Series of Interactive Cardiology MCQs 10 - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"Advanced Clinical Series Cardiology MCQs: Part 10 Master-level assessment spanning complex hemodynamics, electrophysiology, structural interventions, and landmark clinical trials. Live Score 0 \/ 25 Progress 0\/25 1. Which of the following represents the classic electrocardiographic hallmark of Brugada Syndrome Type 1? A) Coved ST segment elevation &gt; 2mm in V1-V3 followed by a negative T [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-23T09:14:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-23T09:38:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-10-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1261\" \/>\n\t<meta property=\"og:image:height\" content=\"706\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-10\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-10\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"New Series of Interactive Cardiology MCQs 10\",\"datePublished\":\"2026-10-23T09:14:46+00:00\",\"dateModified\":\"2026-10-23T09:38:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-10\\\/\"},\"wordCount\":1122,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-10\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-10-2.jpg\",\"articleSection\":[\"Cardiology MCQ\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-10\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-10\\\/\",\"name\":\"New Series of Interactive Cardiology MCQs 10 - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-10\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-10\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-10-2.jpg\",\"datePublished\":\"2026-10-23T09:14:46+00:00\",\"dateModified\":\"2026-10-23T09:38:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-10\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-10\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-10\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-10-2.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-10-2.jpg\",\"width\":1261,\"height\":706},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-10\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Series of Interactive Cardiology MCQs 10\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Series of Interactive Cardiology MCQs 10 - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/","og_locale":"en_US","og_type":"article","og_title":"New Series of Interactive Cardiology MCQs 10 - All About Cardiovascular System and Disorders","og_description":"Advanced Clinical Series Cardiology MCQs: Part 10 Master-level assessment spanning complex hemodynamics, electrophysiology, structural interventions, and landmark clinical trials. Live Score 0 \/ 25 Progress 0\/25 1. Which of the following represents the classic electrocardiographic hallmark of Brugada Syndrome Type 1? A) Coved ST segment elevation &gt; 2mm in V1-V3 followed by a negative T [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-10-23T09:14:46+00:00","article_modified_time":"2026-10-23T09:38:54+00:00","og_image":[{"width":1261,"height":706,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-10-2.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"New Series of Interactive Cardiology MCQs 10","datePublished":"2026-10-23T09:14:46+00:00","dateModified":"2026-10-23T09:38:54+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/"},"wordCount":1122,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-10-2.jpg","articleSection":["Cardiology MCQ"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/","url":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/","name":"New Series of Interactive Cardiology MCQs 10 - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-10-2.jpg","datePublished":"2026-10-23T09:14:46+00:00","dateModified":"2026-10-23T09:38:54+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-10-2.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-10-2.jpg","width":1261,"height":706},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-10\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"New Series of Interactive Cardiology MCQs 10"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=67964"}],"version-history":[{"count":4,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67964\/revisions"}],"predecessor-version":[{"id":67969,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67964\/revisions\/67969"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/67965"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=67964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=67964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=67964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}